WorldCare Clinical announced new rapid turnaround services for imaging safety reviews. The new service offering is designed to deliver safety assessments within 24 hours of receiving scans.
WCC is providing new rapid safety assessment services in response to the growing emphasis that regulatory agencies are placing on safety reviews. Through its affiliation with Proscan Reading Services (PRS), a provider of large-volume teleradiology services accredited by the American College of Radiology, WCC is offering an integrated reading service that provides comprehensive safety assessments within 24 hours of receiving scans, seven days a week and can deliver emergency reads even faster, if required. Using an in-house team of practicing, board-certified, sub specialty-trained radiologists, WCC assembles reading teams that have extensive experience relevant to the disease population being studied.
“Efficacy assessments in imaging studies are often facilitated by a batch review, which can result in extended delays in determining incidental safety findings,” said Richard Walovitch, PhD, president of WorldCare Clinical, LLC. “We understand the time-critical nature of these assessments and have developed this integrated reading service to address the need for prompt and accurate safety assessments.”
Using WCC’s proven WorldPRO image management platform, a comprehensive system that collects, anonymizes, integrates, and presents imaging data to multiple reviewers in a regulatory-compliant, efficient and effective manner, the new rapid turnaround safety assessment service includes the following key functions:
· An asynchronous upload ability that allows sites to queue up multiple images for electronic submission; files are transferred automatically for aquick turnaround, decreasing the time and cost of sending data by courier.
· Integration with a web-based viewer enabling radiologists to complete safety reviews anytime, anywhere.
· Automatic notifications sent immediately to the site upon completion of the safety review.
For more information about WCC’s full range of services, including its imaging safety review services, visit: http://www.wcclinical.com/what-we-do/#page-Special-Services.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.